Concept and progress in the development
β
William S. Craig; Soan Cheng; Daniel G. Mullen; Jon Blevitt; Michael D. Pierschb
π
Article
π
1995
π
Wiley (John Wiley & Sons)
π
English
β 106 KB
π 2 views
The cell adhesion domain, arginine-glycine-aspartic acid (RGD), has been incorporated into synthetic peptides to perform either of two modes of drug action, antagonist or agonist. Short, conformationally constrainedpeptides have been developed as antagonists for the platelet membrane glycoprotein co